Global HIV, Hepatitis and STIs Programmes

The Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes leads the development and implementation of the global health sector strategy on the elimination of the diseases as public health threats.

About us

Vision

To lead the global effort to end the epidemics of HIV, Tuberculosis (TB), Hepatitis, and Sexually Transmitted Infections (STIs), ensuring that every person has equitable access to highest-quality people-centred scientific evidence and services, regardless of who they are or where they live.

To develop and implement evidence-based normative guidance and standards, leveraging data and science, to ensure access to the latest health innovations, across the full continuum of public health, prevention, diagnosis, treatment, and care.

To safeguard and expand access to essential services for HIV, TB, Hepatitis and STIs and their determinants including for key and vulnerable populations, in collaboration with key multisectoral stakeholders and communities, while contributing to strengthening health systems, enhancing health and well-being and saving lives.

To achieve this vision, the Department for HIV, TB, Hepatitis, and STIs focuses on 7 priorities

1	Leadership: Lead the global effort to end the epidemics of HIV, TB, Hepatitis, and STIs by shaping strategies, catalyzing political and multisectoral commitment, and driving accountability, advocacy, and partnerships.
2	Evidence-based normative guidance development: Develop and implement highest quality, evidence-based, high-impact norms and standards in engagement with strategic partners.
3	Capacity building and policy implementation: With RO and CO support countries in translating global guidance into action through technical assistance especially in high-burden settings
4	With Country Offices, Regional Offices, WHO-HQ, Member States and partners: We will work to enhance cohesion and maximize synergies across the three levels of WHO. With greater clarity and definition on roles and responsibilities to maximize our collective impact, with each focused on our core mandates
5	Data for monitoring disease burden and impact: Strengthen the use of strategic information to monitor burden, assess impact, guide decisions, and track progress toward 2030 targets.
6	Health equity and community engagement: Integrate equity, gender, and rights including addressing key and vulnerable populations; and position communities and civil society as central actors in addressing social determinants and driving integrated responses.
7	Research agenda: Shape and promote research & innovation, facilitate the equitable scaling up of innovative health interventions, and delivery models